Rachel Flehinger
Articles by Rachel Flehinger
| 3 min read
MANF Therapeutics restarts IND-enabling work in light of new results
| 3 min read
Melinta Therapeutics seeks to move investigational pyrrolocytosine compounds into clinical stage
| 3 min read
A pair of new deals with Daiichi and Takeda help move Thermo’s technology forward
| 3 min read
Sutro Biopharma advances STRO-001 and STRO-002 into the clinic against multiple cancer types
| 3 min read
Scripps scientists use 3D spheroids to better test cancer drugs’ efficacy
| 3 min read
Combination of immune agonists may fight one of the fastest-moving and deadliest of cancers
| 3 min read
QIAGEN acquires molecular diagnostics company STAT-Dx and its multiplex technologies
| 2 min read
With half of CAR-T studies in China, Cesca looks to capitalize on market potential with CDMO expansion
| 3 min read
CD133 revealed as a potential target for encouraging kidney repair
| 3 min read
Kinase inhibitor may prove useful in treating rare genetic disease
Page 1 of 6 - 81 Total Items
Subscribe to our eNewsletters
Stay connected with all of the latest from Drug Discovery News.
SubscribeSponsored
Discovering deeper insights into malaria research
Malaria continues to drive urgent research worldwide, with new therapies and tools emerging to combat the parasite’s complex lifecycle and global burden.
Accelerating RNA therapeutic testing with liver microphysiological platforms
Researchers can now study oligonucleotide delivery and efficacy in a system that models a real human liver.
Shining light on the subcellular proteome
Discover how innovative proteomics tools help researchers peer into once inaccessible organelles, allowing for new targets for drug discovery and development.
